Skip to content

taoc and vaping

taoc and vaping - taoc and vaping

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000051684
Enrollment
34
Registered
2023-07-21
Start date
2022-07-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The lack of clarity regarding the effect of switching to vaping from tobacco cigarettes on gingival health

Interventions

smoking vaping

Sponsors

Universitas Padjadajaran
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: smokers

Exclusion criteria

Exclusion criteria: having an acute illness that required treatment (subjects who had a viral infection) within 4 weeks before the enrolment visit, having oral soft tissue disease or any type of gingival overgrowth other than those caused by plaque, suffering from periodontitis, having a history of tooth loss due to periodontitis, being treated with anticoagulant therapy in the previous six months, using prostheses or orthodontic appliances, history of alcoholism or drug/chemical abuse, taking any drug or substance (other than tobacco) that interferes with the cyclooxygenase pathway (e.g. anti-inflammatory drugs including aspirin and ibuprofen) in the 14 days prior to the enrolment visit, taking antibiotics in the 14 days prior to the enrolment visit, breastfeeding or pregnant women.

Design outcomes

Primary

MeasureTime frame
taoc increased.

Countries

Asia(except Japan)

Contacts

Public ContactIndra Pribadi

Universitas Padjadjaran Periodonsia

indra.mustika@unpad.ac.id+628562143662

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026